Asston Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
APL
Other Electrical Equipment
Track Asston Pharmaceuticals share price live with TickJournal's free stock screener.
Browse APL cash flow statement to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Asston Pharmaceuticals Market Cap
₹59.70 Cr.
APL P/E Ratio (TTM)
-
Asston Pharmaceuticals P/B Ratio
-
EPS (TTM)
₹6.14
Dividend Yield
-
Debt to Equity
0.77
APL 52 Week High
-
Asston Pharmaceuticals 52 Week Low
-
Operating Margin
-
Profit Margin
-
APL Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹28.00
Total Equity
₹11.00
Asston Pharmaceuticals Share Price History - Stock Screener Chart
Screen APL historical share price movements with interactive charts. Analyze price trends and patterns.
Asston Pharmaceuticals Company Profile - Fundamental Screener
Screen Asston Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for APL shares.
Sector
Capital Goods
Industry
Other Electrical Equipment
Sub-Sector
Other Electrical Equipment
Segment
E
ISIN
INE0SJX01015
Asston Pharmaceuticals Balance Sheet Screener
Screen APL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 28 | 20 | 14 | 10 |
| Current Assets | 27 | 18 | 11 | 7 |
| Fixed Assets | 1 | 1 | 1 | 1 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 2 | 2 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 11 | 6 | 2 | 1 |
| Share Capital | 6 | 1 | 1 | 1 |
| Reserves & Surplus | 5 | 6 | 1 | 0 |
Asston Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Asston Pharmaceuticals income statement and profit fundamentals.
Analyze APL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Asston Pharmaceuticals share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Revenue | 0 | 26 | 16 | 7 | 11 |
| Expenses | 0 | 20 | 13 | 5 | 10 |
| EBITDA | 0 | 6 | 3 | 2 | 1 |
| Operating Profit % | 0.00% | 22.00% | 16.00% | 23.00% | -4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 0 | 5 | 2 | 1 | 0 |
| Tax | 0 | 1 | 1 | 0 | 0 |
| Net Profit | 0 | 4 | 1 | 1 | 0 |
| EPS | 0.00 | 6.14 | 2.37 | 1.89 | 11.62 |
Asston Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen APL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 0 | -4 | 0 | -1 |
| Investing Activities | 1 | 0 | -1 | 0 |
| Financing Activities | -1 | 4 | 1 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
Asston Pharmaceuticals Shareholding Pattern Screener
See Asston Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Asston Pharmaceuticals promoter holding and ownership changes for APL on TickJournal.
| Item | 2025-Jan | 2025-Jun | 2025-Jul | 2025-Sept |
|---|---|---|---|---|
| Promoter Holding | 69.07% | 50.66% | 68.76% | 50.66% |
| FII Holding | 0.00% | 9.70% | 0.00% | 6.04% |
| DII Holding | 0.00% | 4.08% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 0.00% | 30.95% | 0.00% | 37.06% |
| Other Holding | 30.93% | 4.61% | 31.24% | 6.24% |
| Shareholder Count | 104 | 662 | 128 | 751 |
Asston Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Asston Pharmaceuticals dividend history with payout and yield data.
View Asston Pharmaceuticals dividend details including ex-dates and amounts for APL stock.
Asston Pharmaceuticals Stock Index Membership
See which indices include Asston Pharmaceuticals stock.
Check APL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Asston Pharmaceuticals Market Events Screener - Corporate Actions
Get Asston Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Asston Pharmaceuticals stock events that may affect APL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -6.17% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.65% |
Asston Pharmaceuticals Competitors Screener - Peer Comparison
Screen APL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Waaree Energies | 91,064 | 26.69 | 14,846 | 27.62% | 1,928 | 67.62 |
| Premier Energies | 39,173 | 29.41 | 6,652 | 109.76% | 937 | 70.42 |
| Apar Industries | 38,855 | 39.58 | 18,681 | 15.07% | 821 | 50.19 |
| Emmvee Photovoltaic Power | 15,825 | 17.88 | 2,360 | 147.31% | 369 | 62.53 |
| Genus Power Infrastructures | 7,271 | 13.66 | 2,525 | 98.10% | 295 | 38.75 |
| Vikram Solar | 6,978 | 15.21 | 3,460 | 37.06% | 140 | 50.97 |
| Avalon Technologies | 6,352 | 64.76 | 1,115 | 26.44% | 63 | 50.60 |
| Saatvik Green Energy | 4,727 | 11.90 | 2,193 | 99.83% | 214 | 51.38 |
| Shilchar Technologies | 4,550 | 24.08 | 640 | 56.11% | 147 | 55.10 |
| Oriana Power | 3,550 | 22.26 | 998 | 158.71% | 159 | 42.02 |
Asston Pharmaceuticals Company Announcements - News Screener
Screen APL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-02-07 | Cancellation of Board Meeting | - |
| 2026-01-30 | Closure of Trading Window | - |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors | - |
| 2026-01-29 | Board Meeting Intimation for Increasing Of Authorised Capital And Raising Of Funds | - |
| 2026-01-21 | Commencement Of Commercial Production | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-01-05 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-01-02 | Board Meeting Intimation for Considering Loan Facility From HDFC Bank Ltd. | - |
| 2025-11-14 | Regulation 30 SEBI (LODR) Regulation Update. | - |
| 2025-11-14 | Unaudited Financial Results For The Half Year Ended 30Th September 2025 Along With A Limited Review Report | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2025-11-11 | Board Meeting Intimation for Intimation Of Board Meeting | - |
| 2025-10-17 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-10-16 | General Announcement | - |
| 2025-10-16 | Meeting Updates | - |
| 2025-10-16 | Appointment of Company Secretary and Compliance Officer | - |